Sharing individual patient data from clinical trials to catalyze new treatments http://t.co/Ol5ee6wqNJ @NEJM great last sentence #indivmedIt is ironic that the organizations that most resist wider access to data are the ones that stand to benefit so much from greater transparency.
— Eric Topol (@EricTopol) October 23, 2013
http://www.nejm.org/doi/full/10.1056/NEJMp1310771
Aucun commentaire:
Enregistrer un commentaire